Search EdNeuro Page
The search found 4 results in 0.115 seconds.
Search results
Results of the FOCUS clinical trial led by Professor Martin Dennis and Professor Gillian Mead (Centre for Clinical Brain Sciences), which tested the efficacy of fluoxetine to improve physical ability in stroke patients indicated that there was no improvement in patients given this drug compared with patients given a placebo drug.
Professor Joanna Wardlaw (Centre for Clinical Brain Sciences) is leading a new research trial funded by the British Heart Foundation focusing on whether existing drugs could be used to prevent cognitive decline and dementia after stroke.
Dr Mark Rodrigues, Professor Rustam Al-Shahi Salman (both Centre for Clinical Brain Sciences) and colleagues have published findings indicating that detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan. Their findings suggest that a genetic test for APOE, combined with a CT scan, could be used to detect stroke caused by intracerebral haemorrhage (ICH).
A major study investigating links with dementia is being led by Professor Joanna Wardlaw and colleagues at the University of Edinburgh, in collaboration with 9 UK universities. The £1.2 million project aims to improve how doctors identify and treat dementia that occurs following a stroke.